Search results for "MCI"

showing 10 items of 228 documents

Contaminants of emerging concern in the environment. Turia River as study case

2018

Tesis llevada a cabo para conseguir el grado de Doctor por la Universidad de Valencia.--2018-04-05

drogas de abusoQuEChERScontaminantes emergentesmétodo analíticotriple quadrupolo:QUÍMICA::Química analítica::Análisis cromatográfico [UNESCO]Tampón de McIlvaineMS/MSProductos de cuidado personalUNESCO::QUÍMICA::Química analítica::Análisis cromatográficoUNESCO::CIENCIAS DE LA TIERRA Y DEL ESPACIO::Hidrología ::Aguas superficialesHPLCQToFfármacos:CIENCIAS DE LA TIERRA Y DEL ESPACIO::Hidrología ::Aguas superficiales [UNESCO]Extracción en fase sólida
researchProduct

CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Mult…

2017

Purpose Gemcitabine is standard of care in the adjuvant treatment of resectable pancreatic ductal adenocarcinoma (PDAC). The epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in combination with gemcitabine has shown efficacy in the treatment of advanced PDAC and was considered to improve survival in patients with primarily resectable PDAC after R0 resection. Patients and Methods In an open-label, multicenter trial, patients were randomly assigned to one of two study arms: gemcitabine 1,000 mg/m2 days 1, 8, 15, every 4 weeks plus erlotinib 100 mg once per day (GemErlo) or gemcitabine (Gem) alone for six cycles. The primary end point of the study was to improve disease-fre…

0301 basic medicineOncologyCancer Researchmedicine.medical_specialtymedicine.medical_treatmentlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineMulticenter trialPancreatic cancermedicineClinical endpointChemotherapybusiness.industrymedicine.diseaseGemcitabine3. Good healthClinical trial030104 developmental biologyOncology030220 oncology & carcinogenesisErlotinibbusinessmedicine.drugJournal of Clinical Oncology
researchProduct

Evolution of external female genital mutilation : why do males harm their mates?

2017

Sperm competition may select for male reproductive traits that influence female mating or oviposition rate. These traits may induce fitness costs to the female; however, they may be costly for the males as well as any decrease in female fitness also affects male fitness. Male adaptations to sperm competition manipulate females by altering not only female behaviour or physiology, but also female morphology. In orb-weaving spiders, mating may entail mutilation of external structures of the female genitalia, which prevents genital coupling with subsequent males. Here, we present a game theoretical model showing that external female genital mutilation is favoured even under relatively high cost…

10010106 biological sciences0301 basic medicineFemale circumcisionharmful male traitAntagonistic CoevolutionBiology010603 evolutionary biology01 natural sciencessperm competitionAndrology03 medical and health sciences5. Gender equalitysexual selectionSex organhämähäkkieläimetMatinglcsh:ScienceSperm competitionreproductive and urinary physiologyMultidisciplinarylisääntymiskäyttäytyminen70203Biology (Whole Organism)14mating costs16. Peace & justicelisääntyminen030104 developmental biologyHarmsukupuolivalintaparinvalintaSexual selectionta1181lcsh:QSperm precedencegenital damageResearch ArticleDemography
researchProduct

Intralesional corticosteroid injections in the treatment of central giant cell lesions of the jaws: A meta-analytic study

2013

Objective: The aim of this study was to evaluate the response of treatment of central giant cell lesion to intralesional corticosteroid injections. Study Design: Review of articles indexed in PubMed on the topic between the years 1988 and 2011, and development of a descriptive meta-analysis of the results. Results: Sample of 41 patients primarily treated with intralesional corticosteroid injections was obtained, with a male female ratio of 1:0.95, being 23 aggressive and 18 non-aggressive central giant cell lesions. Triamcinolone acetonide and triamcinolone hexacetonide were the drugs used, and 78.0% cases were considered as good result, 14.6% were considered as moderate response and 7.3% w…

Malemedicine.medical_specialtyTriamcinolone acetonidemedicine.drug_classOdontologíaInjections IntralesionalIntralesional corticosteroidLesionAdrenal Cortex HormonesmedicineHumansGiant Cell TumorsGeneral DentistryTriancinolona AcetonidaOral Medicine and Pathologybusiness.industryGiant Cell TumorsMale femaleReview-ArticleCorticosteroides:CIENCIAS MÉDICAS [UNESCO]Jaw NeoplasmsCiencias de la saludResponse to treatmentSurgeryOtorhinolaryngologyGiant cellUNESCO::CIENCIAS MÉDICASCorticosteroidFemaleSurgerymedicine.symptombusinessmedicine.drugMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer

2014

Lung cancer is the most common cause of cancer-related mortality worldwide, urging the discovery of novel molecular targets and therapeutic strategies. Stem cells have been recently isolated from non-small cell lung cancer (NSCLC), thus allowing the investigation of molecular pathways specifically active in the tumorigenic population. We have found that Bcl-XL is constantly expressed by lung cancer stem cells (LCSCs) and has a prominent role in regulating LCSC survival. Whereas chemotherapeutic agents were scarcely effective against LCSC, the small molecule Bcl-2/Bcl-XL inhibitor ABT-737, but not the selective Bcl-2 inhibitor ABT-199, induced LCSC death at nanomolar concentrations. Differen…

Lung NeoplasmsMice SCIDPharmacologyPiperazinesAntineoplastic AgentNitrophenolsMiceMice Inbred NODCarcinoma Non-Small-Cell LungCytotoxic T cellNon-Small-Cell Lungeducation.field_of_studySulfonamidesTumorAnimals; Antineoplastic Agents; Biphenyl Compounds; Carcinoma Non-Small-Cell Lung; Cell Line Tumor; Cell Proliferation; Cell Survival; Female; Humans; Lung Neoplasms; Mice Inbred NOD; Mice SCID; Neoplastic Stem Cells; Nitrophenols; Piperazines; Sulfonamides; Tumor Burden; Xenograft Model Antitumor Assays; bcl-X Protein; Molecular Biology; Cell BiologyTumor BurdenAnimals; Antineoplastic Agents; Biphenyl Compounds; Carcinoma Non-Small-Cell Lung; Cell Line Tumor; Cell Proliferation; Cell Survival; Female; Humans; Lung Neoplasms; Mice Inbred NOD; Mice SCID; Neoplastic Stem Cells; Nitrophenols; Piperazines; Sulfonamides; Tumor Burden; Xenograft Model Antitumor Assays; bcl-X ProteinNeoplastic Stem CellsFemaleStem cellHumanmedicine.drugXenograft Model Antitumor AssayCell SurvivalPopulationbcl-X ProteinAntineoplastic AgentsBiologySCIDSulfonamideCell LineCancer stem cellCell Line TumormedicineAnimalsHumanseducationLung cancerPiperazineMolecular BiologyCell ProliferationSettore MED/04 - Patologia GeneraleOriginal PaperNitrophenolAnimalCell growthCarcinomaBiphenyl CompoundsCell Biologymedicine.diseaseXenograft Model Antitumor AssaysGemcitabineLung NeoplasmCell cultureBiphenyl CompoundCancer researchInbred NODNeoplastic Stem Cell
researchProduct

Cultural Beliefs, Perceptions, and Experiences on Female Genital Mutilation Among Women and Men: A Qualitative Analysis.

2021

The practice of female genital mutilation (FGM) is a deeply-rooted tradition that affects predominantly regions of Africa and Asia. Because of migration flows, FGM is an issue of increasing concern worldwide. FGM is now carried out in Europe, North America, Australia and New Zealand, and more specifically among immigrant communities from countries where it is common. This study aims to assess the experience, knowledge, attitudes, and beliefs related to FGM of migrant women and men from FGM-affected countries residing in Spain and the United Kingdom. A phenomenological qualitative approach was used. Participants (n=23) were recruited by using the snowball sampling technique until data satur…

Female circumcisionMaleHealth Knowledge Attitudes Practicemedia_common.quotation_subject050901 criminology05 social sciencesEmigrants and ImmigrantsFocus GroupsCultural beliefsDevelopmental psychologyClinical PsychologyQualitative analysisSpainPerceptionCircumcision FemaleHumans0501 psychology and cognitive sciencesFemale0509 other social sciencesPsychologyApplied Psychology050104 developmental & child psychologyQualitative researchmedia_commonJournal of interpersonal violence
researchProduct

Female Genital Mutilation Consequences and Healthcare Received among Migrant Women: A Phenomenological Qualitative Study

2021

European healthcare systems are increasingly being challenged to respond to female genital mutilation (FGM). This study explores the FGM experiences of migrant women coming from FGM-practicing countries residing in a European host country. A qualitative phenomenological study was carried out and 23 participants were included. Data were collected through 18 face-to-face open-ended interviews and a focus group and were analysed using Giorgi’s four-step phenomenological approach. Three main themes were derived: “FGM consequences”, “healthcare received” and “tackling FGM”. Participants highlighted obstetric, gynaecological and genitourinary consequences such as haemorrhages, perineal tears, cae…

medicine.medical_specialtyHealth Toxicology and MutagenesisHuman sexualityfemale genital mutilationmigrationArticlefemale circumcision03 medical and health sciences0302 clinical medicinenursingPregnancywomen’s healthHealth carehealth consequencesmedicineHumans030212 general & internal medicinemidwiferyhealth equity030219 obstetrics & reproductive medicinebusiness.industryRisk of infectionRPublic Health Environmental and Occupational HealthHumiliationFocus groupHealth equityEuropeSexual intercourseGynecologyFamily medicineCircumcision FemaleMedicineFemalebusinessPsychologyDelivery of Health Carequalitative researchQualitative researchInternational Journal of Environmental Research and Public Health
researchProduct

Safety and effectiveness of gemcitabine for the treatment of classic Kaposi’s sarcoma without visceral involvement

2022

Background: Classic Kaposi’s sarcoma (CKS) is a rare, multifocal, endothelial cell neoplasm that typically occurs in elderly people with previous infection by human herpes virus-8. Prospective trials are rare, and the choice of drugs relies on prospective trials performed on HIV-associated Kaposi’s sarcoma (KS). Pegylated liposomal anthracyclines and taxanes are considered the standard first- and second-line chemotherapy, respectively. Despite the indolent biologic behavior, the natural history is characterized by recurrent disease. This condition of chronic administration of cytotoxic drugs is often associated with immediate/long-term adverse events. Methods: This was an observational, ret…

Kaposi’s sarcomaOncologygemcitabine
researchProduct

Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E a…

2009

Background:Two parallel randomized phase 2 trialswere performed to choose the optimal way of combining cetuximab with gemcitabine in the first-line treatment of elderly (CALC1-E) and adult PS2 (CALC1-PS2) patients with advanced NSCLC. Methods: Stage IV or IIIB NSCLC patients, aged ≥70 years with PS 0–2 for CALC1-E or aged <70 with PS2 for CALC1-PS2, not selected for EGFR expression,were eligible. Patients were randomized to concomitant (gemcitabine, for a maximum of 6 cycles, plus cetuximab until progression) or sequential (gemcitabine, for a maximum of 6 cycles, followed by cetuximab) strategy. A selection design, with 1-year survival rate as the primary endpoint, was applied, requiring 58…

Pulmonary and Respiratory MedicineOncologyAdultMaleCancer Researchmedicine.medical_specialtyLung NeoplasmsAdolescentSettore MED/06 - Oncologia MedicaCetuximabNSCLCAntibodies Monoclonal HumanizedDeoxycytidinelaw.inventionYoung AdultRandomized controlled triallawInternal medicineCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansLung cancerPS2 patientSurvival analysisAgedCetuximabbusiness.industryCancerAntibodies MonoclonalMiddle Agedmedicine.diseaseGemcitabineGemcitabineSurgeryClinical trialTreatment OutcomeOncologyConcomitantPatient ComplianceFemalebusinessElderly patientmedicine.drug
researchProduct

Treatment of recurrent aphthous stomatitis. A literature review

2014

Recurrent aphthous stomatitis (RAS) is the most common chronic disease of the oral cavity, affecting 5-25% of the population. The underlying etiology remains unclear, and no curative treatment is available. The present review examines the existing treatments for RAS with the purpose of answering a number of questions: How should these patients be treated in the dental clinic? What topical drugs are available and when should they be used? What systemic drugs are available and when should they be used? A literature search was made of the PubMed, Cochrane and Scopus databases, limited to articles published between 2008-2012, with scientific levels of evidence 1 and 2 (metaanalyses, systematic …

medicine.medical_specialtyPathologyTriamcinolone acetonidePopulationOdontologíaReviewRecurrent aphthous stomatitislaw.inventionRandomized controlled trialPrednisonelawmedicineeducationGeneral Dentistryeducation.field_of_studyOral Medicine and Pathologybusiness.industry:CIENCIAS MÉDICAS [UNESCO]DermatologyCiencias de la saludThalidomideSystematic reviewAmlexanoxUNESCO::CIENCIAS MÉDICASbusinessmedicine.drug
researchProduct